Pharmaceuticals stocks in India
Every listed pharmaceuticals company on NSE and BSE in our database, largest first, with its valuation, profitability, latest quarterly growth, one-year return and next results date.
There are 228 listed companies in the Pharmaceuticals industry on NSE and BSE in our database, 130 of them with full financials.
The largest by market capitalisation are Sun Pharmaceutical Industries Limited (₹419,404 Cr), Divi's Laboratories Limited (₹237,594 Cr), Torrent Pharmaceuticals Limited (₹172,094 Cr).
Among the 101 companies worth more than ₹500 Cr, the median P/E of the profitable ones is 35.0 and the median return on equity is 12.6%.
Fastest sales growth in the latest quarter (year on year, above ₹500 Cr): Sai Parenterals +435%, Sun Pharma +314%, Anlon Healthcare +163%.
Next to report results: Sat Kartar on 24 Oct, Mankind Pharma on 26 Oct, Eris Lifesciences on 26 Oct.
Pharmaceuticals companies by market cap
| # | Company | Market cap | P/E | ROE | Qtr sales YoY | Qtr profit YoY | Return 1Y | Next results |
|---|---|---|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries LimitedSUNPHARMA | ₹419,404 Cr | 34.65 | 14.5% | +10.5% | +27.0% | +5.4% | 30 Oct |
| 2 | Divi's Laboratories LimitedDIVISLAB | ₹237,594 Cr | 81.23 | 17.5% | +27.8% | +65.5% | +35.6% | 07 Nov |
| 3 | Torrent Pharmaceuticals LimitedTORNTPHARM | ₹172,094 Cr | 79.82 | 25.7% | +54.8% | +3.3% | +28.0% | — |
| 4 | Zydus Lifesciences LimitedZYDUSLIFE | ₹112,658 Cr | 22.22 | 18.7% | +16.2% | +14.5% | +14.7% | 04 Nov |
| 5 | Cipla LimitedCIPLA | ₹108,093 Cr | 32.21 | 9.7% | +2.3% | -39.2% | -14.7% | 27 Oct |
| 6 | Laurus Labs LimitedLAURUSLABS | ₹106,442 Cr | 97.62 | 20.6% | +29.1% | +123.9% | +125.7% | 29 Oct |
| 7 | Dr. Reddy's Laboratories LimitedDRREDDY | ₹102,416 Cr | 31.30 | 8.6% | -5.6% | -69.2% | -0.9% | — |
| 8 | Mankind Pharma LimitedMANKIND | ₹91,390 Cr | 44.21 | 12.7% | +12.9% | +29.1% | -9.9% | 26 Oct |
| 9 | Aurobindo Pharma LimitedAUROPHARMA | ₹90,432 Cr | 24.37 | 9.8% | +16.3% | +25.2% | +42.1% | — |
| 10 | Lupin LimitedLUPIN | ₹88,202 Cr | 16.47 | 23.9% | +31.9% | +87.8% | -1.1% | 03 Nov |
| 11 | Glenmark Pharmaceuticals LimitedGLENMARK | ₹61,147 Cr | 34.02 | 17.1% | +23.1% | +927.9% | +16.2% | 05 Nov |
| 12 | Alkem Laboratories LimitedALKEM | ₹59,149 Cr | 27.04 | 15.8% | +10.9% | -21.6% | -10.4% | — |
| 13 | Abbott IndiaABBOTINDIA | ₹53,187 Cr | 32.93 | 33.8% | +4.4% | +17.2% | -16.1% | — |
| 14 | Biocon LimitedBIOCON | ₹52,981 Cr | 127.11 | 1.2% | +10.0% | +53.4% | -9.7% | — |
| 15 | IPCA Laboratories LimitedIPCALAB | ₹49,556 Cr | 35.94 | 17.1% | +20.8% | +82.2% | +51.6% | 05 Nov |
| 16 | Gland Pharma LimitedGLAND | ₹46,645 Cr | 45.39 | 9.9% | +22.3% | +96.7% | +47.4% | 06 Nov |
| 17 | Ajanta Pharma LimitedAJANTPHARM | ₹41,035 Cr | 36.15 | 25.1% | +24.8% | +30.9% | +33.6% | 30 Oct |
| 18 | GlaxoSmithKline Pharmaceuticals LimitedGLAXO | ₹40,737 Cr | 38.15 | 47.1% | +16.6% | +15.7% | -11.7% | 03 Nov |
| 19 | Emcure Pharmaceuticals LimitedEMCURE | ₹33,586 Cr | 32.96 | 20.6% | +22.8% | +36.0% | +29.8% | 03 Nov |
| 20 | Sai Life Sciences LimitedSAILIFE | ₹29,635 Cr | 86.41 | 13.8% | +3.8% | +18.2% | +58.5% | 05 Nov |
| 21 | Wockhardt LimitedWOCKPHARMA | ₹29,276 Cr | 82.94 | 7.1% | +25.9% | +199.1% | +32.8% | — |
| 22 | Acutaas Chemicals LimitedACUTAAS | ₹25,689 Cr | 66.41 | — | +59.1% | +70.4% | +102.0% | 27 Oct |
| 23 | Piramal Pharma LimitedPPLPHARMA | ₹25,317 Cr | 102.49 | 3.0% | +17.4% | -161.3% | -1.6% | 27 Oct |
| 24 | Neuland Laboratories LimitedNEULANDLAB | ₹24,204 Cr | 66.36 | 19.5% | +136.3% | +666.0% | +16.5% | 03 Nov |
| 25 | Rubicon Research LimitedRUBICON | ₹23,516 Cr | 81.53 | — | +51.8% | +97.2% | +126.7% | — |
| 26 | Granules India LimitedGRANULES | ₹19,694 Cr | 29.72 | 13.0% | +22.0% | +59.3% | +39.4% | 02 Nov |
| 27 | Cohance Lifesciences LimitedCOHANCE | ₹17,211 Cr | 295.62 | — | -23.1% | -197.4% | -49.9% | — |
| 28 | Shilpa Medicare LimitedSHILPAMED | ₹16,904 Cr | 56.83 | 11.5% | +44.9% | +115.2% | +142.0% | — |
| 29 | Caplin Point Laboratories LimitedCAPLIPOINT | ₹16,890 Cr | 24.90 | 18.9% | +19.6% | +18.8% | +10.3% | — |
| 30 | Pfizer LimitedPFIZER | ₹16,525 Cr | 22.48 | 17.5% | +8.3% | +6.2% | -32.1% | — |
| 31 | Alivus Life Sciences LimitedALIVUS | ₹15,354 Cr | 25.46 | 18.1% | +6.4% | +31.2% | +34.7% | 29 Oct |
| 32 | Onesource Specialty Pharma LimitedONESOURCE | ₹15,299 Cr | — | -0.8% | +37.3% | +0.7% | -27.8% | 27 Oct |
| 33 | Eris Lifesciences LimitedERIS | ₹15,199 Cr | 22.83 | 17.1% | +13.0% | +14.6% | -31.0% | 26 Oct |
| 34 | AstraZeneca Pharma India LimitedASTRAZEN | ₹14,971 Cr | 88.32 | 19.4% | +29.7% | -32.1% | -34.2% | — |
| 35 | Alembic Pharmaceuticals LimitedAPLLTD | ₹14,941 Cr | 21.60 | 12.2% | +25.7% | +12.7% | -18.6% | — |
| 36 | Jubilant Pharmova LimitedJUBLPHARMA | ₹14,861 Cr | 42.29 | 5.0% | +1385.3% | +3217.6% | -12.8% | — |
| 37 | Natco Pharma LimitedNATCOPHARM | ₹14,442 Cr | 13.33 | 11.7% | -44.7% | -55.5% | -3.7% | — |
| 38 | Marksans Pharma LimitedMARKSANS | ₹13,001 Cr | 24.93 | 17.2% | +35.6% | +174.8% | +61.1% | 04 Nov |
| 39 | Concord Biotech LimitedCONCORDBIO | ₹12,860 Cr | 47.15 | 13.5% | +26.2% | +31.0% | -19.5% | 27 Oct |
| 40 | CORONA Remedies LimitedCORONA | ₹12,531 Cr | 63.15 | — | +21.7% | +30.7% | — | 30 Oct |
| 41 | Sudeep Pharma LimitedSUDEEPPHRM | ₹10,913 Cr | 59.19 | — | +26.6% | +30.9% | — | 28 Oct |
| 42 | Akums Drugs and Pharmaceuticals LimitedAKUMS | ₹10,243 Cr | 34.99 | 8.8% | +13.9% | +56.1% | +44.3% | — |
| 43 | Strides Pharma Science LimitedSTAR | ₹9,354 Cr | 24.07 | 12.5% | +11.2% | +50.0% | +25.8% | 29 Oct |
| 44 | Viyash Scientific LimitedVIYASH | ₹9,012 Cr | 66.46 | 4.7% | +128.9% | +560.0% | — | — |
| 45 | Procter & Gamble Health LimitedPGHL | ₹8,325 Cr | 23.24 | 68.2% | +7.3% | +45.7% | -20.2% | 02 Nov |
| 46 | Blue Jet Healthcare LimitedBLUEJET | ₹8,249 Cr | — | — | -17.4% | -14.2% | -29.2% | — |
| 47 | Aarti Pharmalabs LimitedAARTIPHARM | ₹7,443 Cr | 34.94 | 10.0% | +38.7% | +53.8% | -4.1% | 28 Oct |
| 48 | Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹7,399 Cr | 27.83 | — | +6.7% | +12.8% | -32.0% | 28 Oct |
| 49 | Symbiotec Pharmalab LimitedSYMBIOTEC | ₹7,386 Cr | — | — | +7.5% | -53.1% | — | — |
| 50 | Morepen Laboratories LimitedMOREPENLAB | ₹6,769 Cr | 47.88 | 11.3% | +34.1% | +394.0% | +154.8% | 27 Oct |
| 51 | Bliss GVS Pharma LimitedBLISSGVS | ₹6,628 Cr | 46.63 | 11.9% | +37.6% | +15.8% | +308.7% | 29 Oct |
| 52 | Supriya Lifescience LimitedSUPRIYA | ₹6,588 Cr | 33.25 | 16.5% | +30.8% | -30.9% | +13.3% | — |
| 53 | Sanofi India LimitedSANOFI | ₹6,386 Cr | 19.68 | — | +7.8% | +19.3% | -40.9% | 29 Oct |
| 54 | Innova Captab LimitedINNOVACAP | ₹5,650 Cr | 11.37 | 45.6% | +33.9% | +42.3% | +19.7% | — |
| 55 | Senores Pharmaceuticals LimitedSENORES | ₹5,597 Cr | 42.68 | 14.0% | +30.6% | +43.8% | +64.2% | 29 Oct |
| 56 | Sun Pharma Advanced Research Company LimitedSPARC | ₹5,574 Cr | 3.52 | 118.4% | +314.1% | +59.9% | +30.3% | 02 Nov |
| 57 | FDC LimitedFDC | ₹5,514 Cr | 18.92 | 11.7% | +3.0% | +9.5% | -22.3% | 27 Oct |
| 58 | IOL Chemicals and Pharmaceuticals LimitedIOLCP | ₹4,818 Cr | 28.69 | 9.3% | +37.1% | +89.8% | +67.4% | 30 Oct |
| 59 | Novartis IndiaNOVARTIND | ₹4,505 Cr | 46.40 | 11.9% | +18.2% | +14.3% | — | — |
| 60 | RPG Life Sciences LimitedRPGLIFE | ₹4,333 Cr | 36.14 | 19.8% | +15.8% | +17.0% | +13.6% | 29 Oct |
P/E "n/m" means the company made a loss over the last four quarters. Quarterly growth compares the latest quarter with the same quarter a year earlier. "—" means the figure is not available.
More pharmaceuticals companies
Upcoming pharmaceuticals results
Frequently asked questions
Which are the largest pharmaceuticals stocks in India?
By market capitalisation: Sun Pharmaceutical Industries Limited (₹419,404 Cr), Divi's Laboratories Limited (₹237,594 Cr), Torrent Pharmaceuticals Limited (₹172,094 Cr), Zydus Lifesciences Limited (₹112,658 Cr), Cipla Limited (₹108,093 Cr).
How many pharmaceuticals companies are listed in India?
228 companies listed on NSE and BSE are classified in the Pharmaceuticals industry on this page, which merges the exchanges' and data vendors' labels for the same business.
What is the average P/E of pharmaceuticals stocks?
The median P/E of profitable pharmaceuticals companies worth more than ₹500 Cr is 35.0, based on trailing-twelve-month profit and the latest close.
When do pharmaceuticals companies announce their results?
Upcoming board meetings for results: Sat Kartar Life Limited on 24 Oct 2026; Mankind Pharma Limited on 26 Oct 2026; Eris Lifesciences Limited on 26 Oct 2026; Venus Remedies Limited on 26 Oct 2026; Vineet Laboratories Limited on 26 Oct 2026.